CoChat

Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision Medicine

Open access
Ghosh, Debajyoti, Bernstein, Jonathan A., Khurana Hershey, Gurjit K., Rothenberg, Marc E., Mersha, Tesfaye B. · 2018 · Frontiers in Immunology
Cited by 121

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Abstract

Atopic dermatitis (AD) is a complex inflammatory skin disease affecting approximately 280 million people worldwide.1 About 85% of AD cases begin in childhood, a significant portion of which can persist into adulthood.2, 3 Moreover, there is a typical progression of children with AD to food allergy, asthma or allergic rhinitis later in life—a phenomenon known as ‘allergic march’ or ‘atopic march’.4 AD comprises highly heterogeneous sub-phenotypes/endotypes resulting from complex interplay between intrinsic and extrinsic factors, such as environmental stimuli, and genetic factors regulating cutaneous functions (impaired barrier function, epidermal lipid and protease abnormalities), immune functions and the microbiome. Though the roles of high-throughput “omics” integrations in defining endotypes are recognized, current analyses are primarily based on individual omics data and using binary clinical outcomes. Although individual omics analysis, such as genome-wide association studies (GWAS), can effectively map variants correlated with AD, the majority of the heritability and the functional relevance of discovered variants are not explained or known by the identified variants. The limited success of singular approaches underscores the need for holistic and integrated approaches to investigate complex phenotypes using trans-omics data integration strategies. Integrating omics layers (e.g., genome, epigenome, transcriptome, proteome, metabolome, lipidome, exposome, microbiome), which often have complementary and synergistic effects, offers the opportunity to comprehensively understand the flow of information that underlines the biological basis of AD. Overlapped genes among multiple omics types include FLG, SPINK5, S100A8 and SERPINB3 in AD pathogenesis. Overlapping pathways include macrophage, endothelial cell and fibroblast activation pathways, in addition to well-known Th1/Th2 and NFB activation pathways. Interestingly, there was more multi-omics overlap at the pathway level than gene level. Further analysis of multi-omics overlap at the tissue level showed that among 30 tissue types from the GTEx database, skin and esophagus were significantly enriched, indicating the biological interconnection between AD and food allergy. The present work explores multi-omics integration and provides new biological insights to better define the biological basis of AD etiology and confirm previously reported AD genes/pathways. In this context, we also discuss opportunities and challenges introduced by ‘big omics data’ and their integration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.02727

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 121

Metadata

Authors
Ghosh, D., Bernstein, J. A., Khurana Hershey, G. K., Rothenberg, M. E., & Mersha, T. B.
Venue
Frontiers in Immunology
Published
2018-12-12
Volume
9
Pages
2727-2727
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2905330547
Cited by
121
References
37
FWCI
9.47
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision Medicine. https://app.cochat.ai/papers/10.3389/fimmu.2018.02727
The paper
Ghosh, D., Bernstein, J. A., Khurana Hershey, G. K., Rothenberg, M. E., & Mersha, T. B. (2018). Leveraging Multilayered “Omics” Data for Atopic Dermatitis: A Road Map to Precision Medicine. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.02727

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.